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Abstract
Scope: Enhancing the formation and function of brown adipose tissue (BAT) increases
thermogenesis and hence reduces obesity. Thus, we investigate the effects of resveratrol
(Resv) on brown adipocyte formation and function in mouse interscapular BAT (iBAT).
Methods and results: CD1 mice and stromal vascular cells (SVCs) isolated from iBAT were
treated with Resv. Expression of brown adipogenic and thermogenic markers, and
involvement of AMP-activated protein kinase (AMPK)α1 were assessed. In vivo, Resv
enhanced expression of brown adipogenic markers, PR domain-containing 16 (PRDM16) and
thermogenic genes, uncoupling protein 1 (UCP1) and cytochrome C in iBAT, along with
smaller lipid droplets, elevated AMPKα activity and increased oxygen consumption.
Meanwhile, Resv promoted expression of PRDM16, UCP1, PGC1α, cytochrome C and
pyruvate dehydrogenase (PDH) in differentiated iBAT SVCs, suggesting that Resv enhanced
brown adipocyte formation and function in vitro. In addition, Resv stimulated AMPKα and
oxygen consumption in differentiated iBAT SVCs. However, the promotional effects of Resv
were diminished by AMPK inhibition or AMPKα1 knockout, implying the involvement of
AMPKα1 in this process.
Conclusion: Resv enhanced brown adipocyte formation and thermogenic function in mouse
iBAT by promoting the expression of brown adipogenic markers via activating AMPKα1,
which contributed to the anti-obesity effects of Resv.
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Graphical abstract

In vivo, dietary 0.1% Resv promoted brown adipogenesis markers, increased oxygen
consumption, and activated AMPKα activity in iBAT. In vitro, 10 μM Resv elicited the same
effects on differentiated iBAT SVCs. However, the promotional effects of Resv were
abolished by AMPK inhibition or AMPKα1 KO. These data showed that Resv enhanced
brown adipocyte formation and function by activating AMPKα1.
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Introduction
The global epidemic of obesity is increasingly viewed as a serious public health
challenge and a major risk factor for the development of metabolic syndromes such as type 2
diabetes mellitus, dyslipidemia, and cardiovascular disease [1]. In mammals, brown adipose
tissue (BAT) is the major tissue of non-shivering thermogenesis, dissipating energy as heat
due to its high mitochondrial content and rich in uncoupling protein 1 (UCP1) [2, 3].
Although BAT has long been believed to be absent or negligible in adult humans, recent
studies show that adult humans have substantial amounts of functional BAT [4, 5]. The
amount of BAT is negatively correlated with obesity in adults [6]. Thus, enhancement of
BAT formation and function is a useful strategy to prevent obesity and metabolic disease [7,
8].
While there are many transcriptional regulators affecting brown adipocyte formation and
function [9-11], PR domain-containing 16 (PRDM16) is an indispensable transcriptional
factor specifying brown adipogenic program [12, 13]. The expression of PRDM16 leads to
the activation of mitochondrial biogenesis and the expression of genes associated with BAT
function, including UCP1, peroxisome proliferator-activated receptor-γ coactivator 1α
(PGC1α), pyruvate dehydrogenase (PDH), and cytochrome c [14]. Hormones and cytokines
including T3, norepinephrine, bone morphogenetic protein 7 (BMP7), fibroblast growth
factor 21 (FGF21), and natriuretic peptides (NP) can regulate brown adipogenesis through
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altering PRDM16 expression [10, 15]. Furthermore, certain dietary compounds also regulate
BAT formation and function, which may reduce obesity [16-18].
Dietary supplementation of resveratrol (Resv), a natural polyphenol present in grapes,
red wine, peanuts and some berries, has been shown to exert anti-obesity effects [19]. Resv is
able to protect against high-fat diet induced obesity in mice [20, 21], to decrease fat mass in
pigs [22, 23] and to reduce body weight and adipocyte size in obese persons [24, 25]. The
anti-obesity property of Resv may stem from its effects on inhibiting adipogenesis or
lipogenesis [26], promoting lipolysis [27, 28], and inducing browning of white adipose tissue
(WAT) [29]. Resv-induced browning of WAT upregulates UCP1 and elevates thermogenesis
[11, 29]. In addition, Resv increases UCP1 protein level in BAT and skeletal muscle of rat
fed an obesogenic diet [30], consistent with a recent report showing that Resv promotes BAT
thermogenic gene expression and energy metabolism in mice fed a standard diet [31].
However, the effects of Resv on brown adipocyte formation and function remain largely
untested.
A number of studies have demonstrated that AMP-activated protein kinase (AMPK), a
master regulator of energy metabolism [32, 33], is involved in adipose tissue metabolism [21,
34, 35]. More recently, our study demonstrated that Resv induces browning of WAT through
activation of AMPKα1 [29], a predominant isoform expressed and accounted for the majority
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of the total AMPK activity of in adipose tissue [36-38]. However, it is unclear whether
AMPK participates in Resv-mediated regulation of brown adipocyte formation and function.
Thus, the objective of the present study is to elucidate the role of Resv in regulating
brown adipocyte formation and function and to explore the underlying mechanism. Our data
show that Resv enhances brown adipocyte formation and function through activation of
AMPKα1.

Materials and methods
Animals and in vivo study
Twelve 5-month-old CD1 female mice were randomly divided into control and Resv
groups. The mice in control group were fed a high-fat diet (HFD; 45% energy from fat,
D12451, Research Diet, New Brunswick, NJ), while the mice in Resv group were fed a HFD
containing 0.1% (w/w) Resv (Resveratrol 500, purchased from SWANSON ULTRA® and
each capsule contains 500 mg resveratrol). Mice were housed in an environmentally
controlled room on a 12-h light-dark cycle with free access to food and water. The body
weight and food intake were recorded, and metabolic efficiency was subsequently calculated.
After 4 weeks of treatments, mice were euthanized by carbon dioxide anesthesia.
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Interscapular BAT (iBAT) was rapidly isolated and weighed. Left side of the iBAT was
frozen in liquid nitrogen and stored at -80°C until further analyses. A portion of the right side
was fixed in 4% paraformaldehyde for sectioning and staining. Another portion of the right
side was used for tissue oxygen consumption measurement. All animal experiments and care
procedures were performed according to protocols pre-approved by the Institutional Animal
Care and Use Committees (IACUC) at Washington State University.
Stromal vascular cell (SVC) isolation and in vitro differentiation
SVCs were isolated from iBAT as previously described [39]. Briefly, iBAT were
dissected from weaned wild type or RosaCre/AMPKα1flox/flox C57BL/6 mice obtained by
crossing Rosa-Cre mice (Stock No: 004847, Jackson Lab, Bar Harbor, Maine) with AMPKa1
flox/flox (Stock no: 014141, Jackson Lab) [40]), washed with phosphate-buffered saline
(PBS), minced and digested in DMEM/F12 (Life Technologies) containing collagenase D
(0.75 U/ml), dispase II (1 U/ml) (Roche Diagnostics), and 10 mM CaCl2 at 37 ºC for 30~40
min with frequent shaking. Digesta was centrifuged at 400 g for 5 min and the pellet was
re-suspended in DMEM/F12 containing 10% fetal bovine serum (FBS) (Life Technologies),
and then filtered through a 40 µm nylon strainer. The filtrate was centrifuged at 400 g for 5
min, re-suspended in erythrocyte lysis buffer (NH4Cl 154 mM, KHCO3 10 mM, EDTA 0.1
mM, pH 7.4) and incubated at room temperature for 5 min. The resulting suspension was
centrifuged at 400 g for 5 min again, re-suspended in DMEM/F12 containing 10% FBS, 1%
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penicillin-streptomycin solution and grown at 37 ºC in 5% CO2. The medium was changed
every other day [41].
For knockout of AMPKα1, the SVCs isolated from iBAT of weaning
Rosa26Cre/AMPKα1flox/flox mice were treated with 250 nM 4-hydroxytamoxifen (4-OHT) for
2 days to induce acute deletion of AMPKα1 before being induced to undergo brown
adipogenic differentiation [29]. Brown adipogenic differentiation of iBAT SVCs was induced
as previously described [29]. For AMPK inhibitor experiment, the confluent iBAT SVCs
were incubated in differentiated medium supplemented with 10 µM Resv (Sigma) and/or 1
µM Compound C (CC) for 7 days.
In vitro O2 consumption assay
In vitro O2 consumption of differentiated SVCs or iBAT was measured with Thermo
Scientific Orion 3-Star Dissolved Oxygen meter and probe (Thermo Electron Corporation,
Madison, WI) as previously described [29]. O2 consumption was calculated as the rate of
decrease in dissolved oxygen (DO).
Oil-Red O staining
Lipid accumulation in differentiated iBAT SVCs was detected by Oil-Red O staining as
we previously described [29].
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H&E and immunostaining
H&E staining of iBAT and immunostaining of the differentiated iBAT SVCs and iBAT
sections were conducted as previously described [29]. The anti-UCP1 polyclonal antibody
was purchased from Santa Cruz Biotechnology (Dallas, TX, USA) and used at a dilution of
1:200. Adipocyte diameters were measured by Image-Pro Plus 6.0 (Media Cybernetics, Inc.,
Rockville, MD).
Real-time quantitative PCR
The mRNA expression of genes was determined by real-time quantitative PCR as
previously described [42]. Primer sequences (with their respective PCR fragment lengths)
were shown in Table 1.
Western blot analysis
Western blot analysis was performed as previously described [29]. Primary antibodies
used include UCP-1 (1:500, Santa Cruz Biotechnology), PRDM16 (1:1000, Millipore), Cyto
C (1:1000, Cell Signaling), PDH (1:1000, Cell Signaling), AMPKα (1:1000, Cell Signaling),
p-AMPKα at Thr172 (1:1000, Cell Signaling), or β-actin (1:1000, Cell Signaling). Band
density was normalized to the -actin content.
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Statistical analysis
Data are presented as means ± standard error of the means (SEM). In the mouse feeding
trial, individual animal was considered as an experimental unit and six mice in each group
were used. For in vitro cell culture studies, three independent experiments were conducted
with 3 parallel measurements in each experiment. Statistical analysis was performed using
SigmaPlot 12.5 (Systat Software, Inc., San Jose, CA). Differences between means were
determined using Student’s t-test or one-way analysis of variance (ANOVA) followed by
Duncan’s multiple test when appropriate and a confidence level of P < 0.05 was considered
to be statistically significant.

RESULTS
Dietary resveratrol enhanced iBAT formation and function and activated AMPKα in
mice fed HFD
In our previous study, we found that dietary supplementation of 0.1% Resv induced
browning of inguinal subcutaneous WAT (iWAT) in mice fed HFD [29]. Here, we examined
the effects of Resv on the formation and function of iBAT. The average daily food intake
(ADFI) was comparable between control and 0.1% Resv mice (Fig. 1A). However, the
average daily weight gain (ADWG) of 0.1% Resv group was significantly lower than that of
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control group (Fig. 1B). Thus, the metabolic efficiency (ADWG/ADFI) was remarkably
decreased in Resv treated mice (Fig. 1C). Although the iBAT index (iBAT mass/body
weight) was not significantly altered between 0.1% Resv and control mice (Fig. 1D),
noticeable morphological changes in iBAT were observed in Resv treated mice as follows.
Morphologically, there were smaller lipid droplets in the iBAT of Resv-treated mice,
with the diameter of brown adipocytes lower than 15 μm. In contrast, the adipocyte diameter
in the iBAT of control group mice was higher than 18 μm, with the biggest diameter of about
35 μm (see arrow in Fig. 2A). In addition, we analyzed the number of adipocytes in iBAT by
counting nuclei in microscopic fields selected at random and found that the number of nuclei
per field of 0.1% Resv group was significantly more than that of control group, implying that
Resv enhanced the formation of brown adipocytes in vivo. Accordingly, Resv
supplementation increased protein expression of PRDM16 (2.0-fold versus control, P <
0.001) (Fig. 2C, D), a master gene involved in brown adipocyte formation.
We next compared the function of iBAT between control and Resv-treated mice by
examining the expression of thermogenic genes. By immunohistochemical (IHC) staining of
UCP1, we found a markedly increased UCP1 content in the iBAT of Resv treated mice (Fig.
2A). In agreement, the UCP1 protein content in iBAT of the 0.1% Resv group was 1.4-fold
higher than that of the control group (P < 0.05) (Fig. 2C, D). Furthermore, Resv
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supplementation elevated the protein level of cytochrome C (Cyto C) (1.6-fold increase
versus control, P < 0.05).
We have demonstrated that AMPKα mediates resveratrol-induced browning of iWAT
[29]. Thus, we further examined whether AMPKα was activated in the iBAT by Resv. There
was an elevated content of p-AMPKα (2.4-fold versus control, P < 0.01) and an increase in
the ratio of p-AMPKα to t-AMPKα (p-AMPKα/t-AMPKα) (2.5-fold versus control, P <
0.001) in Resv-treated group (Fig. 2C, D), with no difference of total AMPKα (t-AMPKα).
These data suggested that the enhanced formation and function of iBAT induced by dietary
Resv was associated with AMPK activation in mice fed HFD.
Resveratrol exerted dose dependent effects on brown adipogenic differentiation of iBAT
SVCs
To investigate whether Resv indeed promoted brown adipocyte formation and function
in vitro, iBAT SVCs were induced brown adipogenic differentiation, with presence of various
concentrations of Resv. Using Oil-Red O staining, we found that, at high concentrations (20
μM or 40 μM), Resv significantly (P < 0.001) inhibited lipid accumulation in the
differentiated iBAT SVCs after 7-day brown adipogenic differentiation (Fig. 3A, B).
Consistently, high concentrations of Resv significantly reduced the protein contents of
adipogenic markers (PPARγ and aP2) (Fig. 3C, D). In contrast, at the concentration of 10 μM
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or lower, Resv had no effect on lipid accumulation and protein expression of PPARγ and aP2
(Fig. 3C, D). Thus, we used 10 μM Resv in the following in vitro experiments.
Resveratrol enhanced formation and function of brown adipocytes in the differentiated
iBAT SVCs
Although low concentrations of Resv had no effect on lipid accumulation during brown
adipogenic differentiation of iBAT SVCs, we further determined the effects of Resv on the
formation and function of brown adipocytes in vitro by examining the expression of brown
adipogenic marker genes. As shown in Fig. 4A, 10 μM Resv significantly increased the
mRNA level of PRDM16 (1.9-fold versus control, P<0.01) in differentiated iBAT SVCs of
wild-type. In agreement, the protein level of PRDM16 was also markedly elevated in the
Resv treatment group (1.6-fold versus control, P < 0.05) (Fig. 4C, D). In addition, the
expression of Cidea, a gene predominantly expressed in brown adipocytes increased 6.4-fold
(P < 0.01) in the Resv group. Furthermore, Resv stimulated the mRNA expression of PGC1α
(2.1-fold, P < 0.01), the master regulator of mitochondrial biogenesis and oxidative
phosphorylation.
Mitochondrial UCP1 is the key regulator of thermogenesis in the BAT. In the present
study, we found that the mRNA expression of UCP1 was remarkably boosted by Resv in
differentiated iBAT SVCs (6.5-fold versus control, P < 0.001) (Fig. 4A). In addition, based
on immunofluorescence staining, UCP1 expression was higher in the Resv-treated group than
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that in control group (Fig. 4B), which was confirmed by western blotting (UCP1 protein level
was 1.7-fold higher in Resv-treated cells than that of control cells, P < 0.05) (Fig. 4C, D).
Moreover, the protein levels of Cyto C (2.3-fold versus control, P < 0.05) and pyruvate
dehydrogenase (PDH) (1.4-fold versus control, P < 0.05), which represent the mitochondrial
content and metabolic flux, were also elevated by Resv treatment (Fig. 4C, D).
Resveratrol activated AMPKα in differentiated iBAT SVCs of the wild-type but not
AMPKα1 knockout
In vivo, we found that AMPKα was activated by 0.1% Resv supplementation. We
further examined whether AMPKα was activated by Resv in vitro. As shown in Fig. 5, Resv
increased the p-AMPKα level (1.3-fold versus control, P < 0.05) and the ratio of p-AMPKα
to t-AMPKα (1.4-fold versus control, P < 0.05) in differentiated iBAT SVCs of wild type,
with no effect on t-AMPKα. To confirm which isoform of AMPK α-catalytic subunit
participated in this process, the confluent iBAT SVCs isolated from
Rosa26Cre/AMPKα1flox/flox mice were treated with 4-OHT to knockout AMPKα1 acutely
before brown adipogenic differentiation. Following AMPKα1 knockout (KO), the expression
of p-AMPKα and t-AMPKα in differentiated iBAT SVCs was much lower than in wild-type
cells. Moreover, we found that Resv had no effect on the protein levels of p-AMPKα and
t-AMPKα, and the p-AMPKα/t-AMPKα ratio was unalterated in differentiated iBAT SVCs
with AMPKα1 KO (Fig. 5A, B).
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AMPK inhibition or AMPKα1 KO abolished the enhanced brown adipocyte formation
and function induced by resveratrol in differentiated iBAT SVCs
We used Compound C (CC), an inhibitor of AMPK, to further examine the role of
AMPK in regulating Resv-enhanced formation and function of brown adipocytes in
differentiated iBAT SVCs. We found that CC (1μM) had no significant effect on the
expression of brown adipogenic marker (PRDM16) and thermogenic genes (UCP1 and Cyto
C). However, CC eliminated the stimulatory effects of Resv on the expression of PRDM16,
UCP1, Cyto C and PDH (Fig. 6A, B). These findings suggested that AMPKα activation was
involved in Resv-mediated enhancement of brown adipocyte formation and function in
differentiated mouse iBAT SVCs.
We further determined which isoform of AMPK α subunit was associated with the
promotional action of Resv on brown adipocyte formation and function in differentiated
iBAT SVCs through acute AMPKα1 KO. In the absence of AMPKα1, Resv had no effects on
the mRNA expression of PRDM16, UCP1, Cidea and PGC1a (Fig. 6C). Consistently, after
deletion of AMPKα1, the protein levels of PRDM16, UCP1, Cyto C and PDH in the Resv
group did not differ from those in the control group (Figure 6D, E). These results further
showed that AMPKα1 has a mediatory role in this process.
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Resveratrol increased basal oxygen consumption of iBAT and differentiated iBAT SVCs
Previously, we found a significant increase of the oxygen consumption (VO2) in Resv
treated mice [29]. Here, we further explored the effects of Resv on the basal oxygen
consumption of iBAT and differentiated iBAT SVCs in vitro. As shown in Fig. 7A, Resv
significantly increased the basal oxygen consumption of iBAT (1.4-fold versus control,
P<0.01). Similarly, the basal oxygen consumption of differentiated iBAT SVCs in Resv
group was 1.8-fold higher than that of control group (P<0.001) (Fig. 7B). In contrast, after
AMPKα1 KO, the basal oxygen consumption of differentiated iBAT SVCs was not affected
by Resv treatment. Aggregate, these results suggested that AMPKα1 had an essential role in
mediating the stimulatory effect of Resv on oxygen consumption.
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Discussion
Brown and beige adipose tissues have been identified as important therapeutic targets
for combating diet-induced obesity and metabolic disease [43, 44]. In this paper, we
investigated the effects of Resv on brown adipocyte formation and function in mouse iBAT
and explored the underlying mechanism. Our results demonstrated that Resv enhanced the
brown adipocyte formation and function by promoting the expression of brown adipogenic
marker genes through the activation of AMPKα1. This study was an extension of our
previous study [29], where we explored the role and mechanism of Resv in the formation of
beige adipocytes (browning) in inguinal WAT (iWAT). It has been reported that brown and
beige adipocytes have different developmental origins, with brown adipocytes derived from
MYF5+ myogenic cells [45] while beige adipocytes are derived from PDGFRα+ cells [46,
47]. Thus, the possible effects of Resv on brown adipocyte formation and function need to be
further examined.
The dose of Resv (0.1%, 1 g Resv per kg diet) used for in vivo study was selected based
on the previous reports in rat [30, 48], mice [20, 31, 49], pigs [22] and humans [25, 50]. It has
been shown that Resv protects against high-fat diet induced obesity in mice [20, 21]. In
agreement with the previous findings, we found that Resv decreased the average daily weight
gain compared with the control mice when challenged with an obesogenic diet. In the current
study, although the iBAT index was not significantly altered between mice of control and
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0.1% Resv group, obvious morphological changes of iBAT between these two groups were
observed. The iBAT of Resv-treated mice contained considerably smaller lipid droplets than
those seen in the iBAT of control mice. More importantly, there were more brown adipocytes
in the iBAT of Resv-treated mice than control mice, implying that Resv could enhance the
formation of brown adipocytes in vivo. And this was further confirmed by the upregulation of
brown adipogenic marker gene PRDM16 by Resv supplementation.
The change of iBAT morphology might alter the function of brown adipocytes. Indeed,
the expression of thermogenic genes such as UCP1 and Cyto C was higher in the iBAT of
Resv treated mice, suggesting that Resv enhanced brown adipocyte thermogenesis and
protected against obesity. In line with our results, it has been reported that thermogenesis was
involved in the body-fat lowering effects of Resv [30, 31]. Alternatively, the anti-obesity
effects of Resv might also result from its ability to inhibit adipogenesis, suppress lipogenesis,
stimulate lipolysis or induce browning of WAT [29]. Together, our in vivo data strongly
suggest that Resv enhances the formation and function of iBAT in mice fed HFD.
Subsequently, we further performed in vitro studies to address the effects of Resv on
brown adipocyte formation and function in differentiated iBAT SVCs. High concentrations
(20 or 40 μM) of Resv elicited inhibitory effects on lipid accumulation and the expression of
adipogenic marker genes (PPARγ and aP2) during brown adipogenic differentiation of iBAT
SVCs, reminiscent of previous reports on white adipogenesis [26], which could be due to

This article is protected by copyright. All rights reserved.

cytotoxicity, because at concentrations higher than 20 µM, Resv had a significant cytotoxic
effect on adipocytes such as 3T3-L1 and MEF-derived adipocytes [51, 52]. In addition, it was
reported that the plasma Resv concentration was 1.56 ±0.28 μM in rat fed a HFD containing
4 g Resv per kg diet [48]. While in mice fed a HFD containing 0.4% Resv, the highest plasma
Resv concentration was about 0.5 μM [20]. Thus, to exclude the possible cytotoxic effect of
Resv and consider the serum level of Resv, we selected the relative low concentration (10
μM) to conduct in vitro experiments, which is closer to the physiological concentration [20,
48]. Resv indeed affected brown adipocyte formation and function by elevating the
expression of brown adipogenic marker gene (PRDM16) and thermogenic genes such as
UCP1, Cidea, PGC1α, PDH and Cyto C, with no influence on lipid content. These data
strongly suggested that, in agreement with the in vivo findings, Resv could enhance brown
adipocyte formation and function in differentiated mouse iBAT SVCs in vitro.
Enhanced brown adipocyte formation and function might be associated with increased
oxygen consumption and heat production. In our study, we observed a significantly decreased
metabolic efficiency in Resv-treated mice, which might be, at least in part, due to the elevated
energy expenditure. In accordance, our previous study showed that Resv increased oxygen
consumption (VO2) and heat production while decreased respiratory exchange ratio (RER)
(CO2 production/O2 uptake) in mice [29]. To further confirm the role of iBAT in the increase
of oxygen consumption of the whole body, we measured ex vivo oxygen consumption of
iBAT and differentiated iBAT SVCs. We found that the oxygen consumption of tissue
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(iBAT) and cells (differentiated iBAT SVCs) in Resv treated group was significantly higher
than those of control group. In aggregate, these data suggest that Resv promotes brown
adipocyte function by increasing oxygen consumption and heat production, contributing to its
anti-obesity effects.
Several studies have reported that Resv may elicit its anti-obesity effects in part through
the activation of AMPK [48, 53], consistent with our observation of AMPK activation by
Resv. In addition, our in vitro study also revealed that Resv elevated AMPKα activity in
differentiated iBAT SVCs of wild type but not AMPKα1 knockout. Furthermore, AMPKα
inhibition by Compound C completely reversed the stimulatory effects of Resv on the
expression of brown adipogenic marker genes. These results showed that AMPKα was
involved in Resv enhanced formation and function of brown adipocytes.
The predominant isoform of α catalytic subunit expressed in adipose tissue is α1 [36, 37]
and Resv-induced increase of metabolic rate and decrease of fat mass require AMPKα1 but
not AMPKα2 [21]. Thus, we speculated that AMPKα1 but not AMPKα2 participates in Resv
enhanced formation and function of brown adipocyte. To verify, we isolated iBAT SVCs
from Rosa26Cre/Ampkα1flox/flox mice, induced acute AMPKα1 deletion with 4-OHT, and then
induced brown adipogenic differentiation. As expected, only trace amount of p-AMPKα and
t-AMPKα was detected in SVCs after the acute knockout of AMPKα1, showing that α1
isoform accounts for most of the total activity of AMPKα in differentiated iBAT SVCs [37,
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38]. More importantly, after knockout of AMPKα1, the promotional effects of Resv on the
mRNA and/or protein expression of brown adipogenic marker genes were totally abolished.
Furthermore, the increased oxygen consumption was absent in the differentiated iBAT SVCs
with AMPKα1 knockout. Together, these findings showed that AMPKα1 mediated the Resv
stimulated brown adipocyte formation and thermogenic function.
In conclusion, Resv enhanced brown adipocyte formation and function in mice by
stimulating the expression of brown adipogenic marker genes and oxygen consumption,
which appeared to be associated with AMPKα1 activation. These data provided new insights
into the regulation of brown adipocyte formation and function by dietary polyphenols (Resv)
and suggested the potential application of Resv as a nutritional intervention/therapeutic
strategy for the prevention and treatment of obesity and related diseases.
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Figure legends
Fig. 1 Effects of dietary 0.1% resveratrol on average daily food intake (ADFI, A), average
daily weight gain (ADWG, B), metabolic efficiency (ADWG/ADFI, C), and iBAT index (D)
in mice fed HFD. *P < 0.05 versus control.
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Fig. 2 Dietary supplementation of resveratrol enhanced iBAT formation and function in mice
fed HFD. A) Representative images of H&E and UCP1 IHC staining in sections of iBAT of
control and 0.1% Resv treated mice (scale bar, 100 μm). Arrow indicates the large lipid
droplets (diameter ~35 μm) in control group. B) The number of nuclei in microscopic fields
selected at random from H&E stained sections were compared between control and 0.1%
Resv groups. C) Western blot analyses of brown adipogenic marker gene (PRDM16),
thermogenic genes (UCP-1, Cyto C), p-AMPKα and t-AMPKα, and β-actin was used as the
loading control. D) Mean ± SEM of immunoblotting bands and the intensities of the bands
were expressed as arbitrary units. *P < 0.05, **P < 0.01 and *** P < 0.001 versus control.
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Fig. 3 Effects of resveratrol on the lipid accumulation and the expression of adipogenic
marker genes in iBAT SVCs after 7-day brown adipogenic differentiation. A) Oil-Red O
staining of differentiated iBAT SVCs B) The absorbance of the extracted Oil-Red O
measured spectrophotometrically at 530 nm. C) Western blot analysis of adipogenic marker
genes (PPARγ and aP2) of differentiated iBAT SVCs, and β-actin was used as a loading
control. D) Mean ± SEM of immunoblotting bands and the intensities of the bands were
expressed as arbitrary units. **P < 0.01 and *** P < 0.001 versus control.
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Fig. 4 Resveratrol enhanced the expression of brown adipogenic marker genes in
differentiated iBAT SVCs after 7-day brown adipogenic differentiation. A) Relative mRNA
expression of PRDM16, UCP-1, Cidea and PGC-1a in differentiated iBAT SVCs of
wild-type. B) UCP1 immunofluorescence staining of differentiated iBAT SVCs. Nuclei were
stained with DAPI (scale bar, 100 μm). C) Western blot analysis of PRDM16UCP1, PDH
and Cyto C of differentiated iBAT SVCs. β-actin was used as loading control. D) Mean ±
SEM of immunoblotting bands and the intensities of the bands were expressed as arbitrary
units. *P < 0.05, **P < 0.01 and *** P < 0.001 versus control.
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Fig. 5 Resveratrol activated AMPKα in differentiated iBAT SVCs separated from the
wild-type but not AMPKα1 conditional knockout mice. A) Western blot analysis of
p-AMPKα, t-AMPKα of differentiated iBAT SVCs. β-actin was used as loading control. B)
Mean ± SEM of immunoblotting bands and the intensities of the bands were expressed as
arbitrary units. *P < 0.05 versus control.
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Fig. 6 AMPK inhibition or AMPKα1 knockout (KO) eliminated resveratrol-enhanced
expression of brown adipogenic marker genes in differentiated iBAT SVCs. A) Effects of
resveratrol and AMPK inhibitor Compound C (CC) on the protein contents of PRDM16,
UCP-1, Cyto C and PDH in differentiated iBAT SVCs. β-actin was used as loading control.
B) Mean ± SEM of immunoblotting bands and the intensities of the bands were expressed as
arbitrary units. Bars that do not share the same letter are significantly different (P < 0.05). C)
Relative mRNA expression of PRDM16, UCP-1, Cidea and PGC-1a in differentiated iBAT
SVCs with AMPKα1 knockout. D) Western blot analysis of brown adipogenesis marker
genes PRDM16, UCP1, PDH and Cyto C in differentiated iBAT SVCs of AMPKα1 KO.
β-actin was used as loading control. D) Mean ± SEM of immunoblotting bands and the
intensities of the bands were expressed as arbitrary units.
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Fig. 7 Basal O2 consumption of iBAT and differentiated iBAT SVCs. A) Basal O2
consumption of iBAT of control and 0.1% resveratrol treated mice measured as the decrease
in dissolved oxygen (DO). B) Basal O2 consumption of differentiated iBAT SVCs of wild
type and AMPKα1 knockout (KO) from control and resveratrol treated groups. **P < 0.01
and *** P < 0.001 versus control.
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Table 1. The primer sequences used for real-time quantitative PCR

Amplic

Gene

on size

access

(bp)

number

Gene

Forward (5’-3’)

Reverse (3’-5’)

18s

GTAACCCGTTGAACCCCATT

CCATCCAATCGGTAGTAGCG

151

NC_000083.6

Cidea

ATCACAACTGGCCTGGTTACG TACTACCCGGTGTCCATTTCT

136

NM_007702.2

161

XM_00650377

PGC1α CCCTGCCATTGTTAAGACC

TGCTGCTGTTCCTGTTTTC

9.1
PRDM1 CAGCACGGTGAAGCCATTC
6
UCP1

GCGTGCATCCGCTTGTG

ACTGCCACACCTCCAGTCATT CTTTGCCTCACTCAGGATTGG
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87

NM_00129102
9.1

123

NM_009463.3

